Cargando…

Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation

BACKGROUND & AIMS: Uncontrolled liver proliferation is a key characteristic of liver cancer; however, the mechanisms by which this occurs are not well understood. Elucidation of these mechanisms is necessary for the development of better therapy. The oncogene Gankyrin (Gank) is overexpressed in...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Souza, Amber M., Jiang, Yanjun, Cast, Ashley, Valanejad, Leila, Wright, Mary, Lewis, Kyle, Kumbaji, Meenasri, Shah, Sheeniza, Smithrud, David, Karns, Rebekah, Shin, Soona, Timchenko, Nikolai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083020/ https://www.ncbi.nlm.nih.gov/pubmed/30109252 http://dx.doi.org/10.1016/j.jcmgh.2018.05.007

Ejemplares similares

Small Molecule Cjoc42 Improves Chemo-Sensitivity and Increases Levels of Tumor Suppressor Proteins in Hepatoblastoma Cells and in Mice by Inhibiting Oncogene Gankyrin
por: D’Souza, Amber M., et al.
Publicado: (2021)

Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease
por: Cast, Ashley, et al.
Publicado: (2019)

PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma
por: Valanejad, Leila, et al.
Publicado: (2018)

HDAC1-Dependent Repression of Markers of Hepatocytes and P21 Is Involved in Development of Pediatric Liver Cancer
por: Rivas, Maria, et al.
Publicado: (2021)

Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis
por: Nguyen, Phuong, et al.
Publicado: (2018)

Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer
por: D’Souza, Amber M., et al.
Publicado: (2022)

β‐catenin cancer–enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma
por: Gulati, Ruhi, et al.
Publicado: (2022)

Gankyrin activates the hedgehog signalling to drive metastasis in osteosarcoma
por: Wang, Chongchong, et al.
Publicado: (2021)

Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in Tumorigenesis and Metastasis
por: Luo, Xue, et al.
Publicado: (2012)

Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell
por: Chattopadhyay, Anasuya, et al.
Publicado: (2016)

Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient‐Derived Xenograft Models
por: Johnston, Michael Edward, et al.
Publicado: (2021)

Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy
por: Lutz, Maggie, et al.
Publicado: (2023)

Correction of aging phenotype in the liver
por: Rodriguez, Katherine, et al.
Publicado: (2018)

Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway
por: Zhao, X, et al.
Publicado: (2015)

Gankyrin Drives Malignant Transformation of Gastric Cancer and Alleviates Oxidative Stress via mTORC1 Activation
por: Huang, Bo, et al.
Publicado: (2018)

Resurfaced Shape Complementary Proteins That Selectively Bind the Oncoprotein Gankyrin
por: Chapman, Alex M., et al.
Publicado: (2014)

Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
por: Wang, Chengxing, et al.
Publicado: (2021)

De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation
por: Schaub, Johanna R., et al.
Publicado: (2018)

Effects of Ligand Binding on the Mechanical Properties of Ankyrin Repeat Protein Gankyrin
por: Settanni, Giovanni, et al.
Publicado: (2013)

Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma
por: Hwang, Ju-Ae, et al.
Publicado: (2014)

Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance
por: Jing, Hongbiao, et al.
Publicado: (2014)

Characterization of the Binding Interaction between the Oncoprotein Gankyrin and a Grafted S6 ATPase
por: Chapman, Alex M., et al.
Publicado: (2014)

Gankyrin Is Frequently Overexpressed in Cervical High Grade Disease and Is Associated with Cervical Carcinogenesis and Metastasis
por: Liu, Yuan, et al.
Publicado: (2014)

Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma
por: Yang, Chun, et al.
Publicado: (2016)

Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis
por: Zhao, Xiaotong, et al.
Publicado: (2016)

Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma
por: Sakurai, Toshiharu, et al.
Publicado: (2017)

Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma
por: Wang, Chao, et al.
Publicado: (2018)

The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3
por: Sakurai, Toshiharu, et al.
Publicado: (2017)

LMX1B-associated gankyrin expression predicts poor prognosis in glioma patients
por: Guo, Xu, et al.
Publicado: (2020)

The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells
por: Camacho-Moll, Maria E., et al.
Publicado: (2019)

Integrated analysis using ToppMiR uncovers altered miRNA– mRNA regulatory networks in pediatric hepatocellular carcinoma—A pilot study
por: Whyte, Senyo S., et al.
Publicado: (2022)

Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinoma
por: Yang, Chun, et al.
Publicado: (2022)

Deficiency of Gankyrin in the small intestine is associated with augmented colitis accompanied by altered bacterial composition of intestinal microbiota
por: Sakurai, Toshiharu, et al.
Publicado: (2020)

Role of a 19S Proteasome Subunit- PSMD10(Gankyrin) in Neurogenesis of Human Neural Progenitor Cells
por: Sahu, Indrajit, et al.
Publicado: (2019)

Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin
por: Kashyap, Dharmendra, et al.
Publicado: (2021)

Identification of a covalent binder to the oncoprotein gankyrin using a NIR-Based OBOC screening method
por: Maresh, Marianne E., et al.
Publicado: (2021)

Estrogens drive myeloid-derived suppressor cell accumulation
por: Conejo-Garcia, Jose R., et al.
Publicado: (2017)

LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/stat3/akt pathway
por: Song, Xuan, et al.
Publicado: (2013)

Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα
por: Sun, Ying, et al.
Publicado: (2018)

The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin
por: Xu, Xiaoliang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bi1cmij674gugjfi6l4ri60qii